Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA is the transcript encoding the WASF1 protein, also known as WAVE1, which is a critical regulator of actin cytoskeleton dynamics (UniProt P46089). The encoded protein functions as a core component of the WAVE regulatory complex (WRC), activating the Arp2/3 complex to promote branched actin polymerization essential for cell motility and lamellipodia formation (PubMed: 10564660). In the brain, WASF1 mRNA expression is vital for neuronal development, axonal outgrowth, and synaptic plasticity (PubMed: 29335605). Pathologically, elevated levels of WASF1 mRNA are associated with increased invasion and metastasis in various cancers, while mutations in the gene lead to a rare neurodevelopmental disorder (PubMed: 25670297; NIH: GARD). As a therapeutic target, WASF1 mRNA is being explored for modulation via RNA-based technologies such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). These approaches aim to reduce aberrant protein production in oncogenic settings or potentially address toxic gain-of-function in specific genetic conditions. Monitoring the levels of WASF1 mRNA serves as a key biomarker for assessing the efficacy of these transcript-targeted therapies.
Antisense inhibition and RNA interference targeting the transcript to prevent translation or induce degradation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA (WASF1 mRNA).